Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: A retrospective chart review in turkish children with attention deficit hyperactivity disorder [OROS-metilfenidat ir-metilfenidattan daha etkilidir: Dikkat eksikliği hiperaktivite bozukluğu olan türk çocuklarında retrospektif bir araştırma]
dc.contributor.author | Ardic U.A. | |
dc.contributor.author | Ercan E.S. | |
dc.contributor.author | Ercan E. | |
dc.contributor.author | Yuce D. | |
dc.contributor.author | Basay B.K. | |
dc.date.accessioned | 2019-10-27T08:22:24Z | |
dc.date.available | 2019-10-27T08:22:24Z | |
dc.date.issued | 2014 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of this study was to evaluate the efficacy and safety of osmotic release oral system methylphenidate (OROS-MPH) compared with immediate release methylphenidate (IR-MPH) in Turkish children with attention deficit hyperactivity disorder (ADHD).Method: The medical records of primary school-aged children, who were first-time referrals to the outpatient clinic, were reviewed; 67 children receiving OROS-MPH and 47 children receiving IR-MPH were recruited for the study. A total of 114 children receiving treatment for ADHD were evaluated over 8 weeks.Results: The total Turgay DSM-IV Based Child and Adolescent Behavior Disorders Screening and Rating Scale scores from both the parent and teacher forms decreased significantly in both groups over 8 weeks (p<0.001). OROS-MPH was found to be superior to IR-MPH when comparing baseline-to-8th-week- mean inattention score changes on both the teacher (p=0.007) and parent (p=0.015) forms. OROS-MPH and IR-MPH were both well tolerated, with similar side- effect profiles.Conclusion: OROS-MPH was found to be effective and safe in the treatment of ADHD symptoms in Turkish children. © 2014, Cukurova Univ Tip Fakultesi Psikiyatri Anabilim Dali. All rights reserved. | en_US |
dc.identifier.doi | 10.5455/bcp.20141009112739 | |
dc.identifier.endpage | 349 | en_US |
dc.identifier.issn | 1017-7833 | |
dc.identifier.issn | 1017-7833 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 342 | en_US |
dc.identifier.uri | https://doi.org/10.5455/bcp.20141009112739 | |
dc.identifier.uri | https://hdl.handle.net/11454/26244 | |
dc.identifier.volume | 24 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cukurova Univ Tip Fakultesi Psikiyatri Anabilim Dali | en_US |
dc.relation.ispartof | Klinik Psikofarmakoloji Bulteni | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Attention deficit hyperactivity disorder | en_US |
dc.subject | Children | en_US |
dc.subject | Methylphenidate | en_US |
dc.title | Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: A retrospective chart review in turkish children with attention deficit hyperactivity disorder [OROS-metilfenidat ir-metilfenidattan daha etkilidir: Dikkat eksikliği hiperaktivite bozukluğu olan türk çocuklarında retrospektif bir araştırma] | en_US |
dc.type | Article | en_US |